Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease
Jack, Clifford R. , Barkhof, Frederik , Bernstein, Matt A. , Cantillon, Marc, Cole, Patricia E., DeCarli, Charles , Dubois, Bruno , Duchesne, Simon , Fox, Nick C. , Frisoni, Giovanni B. , Hampel, Harald , Hill, David , Johnson, Keith A. , Scheltens, Philip , Schwarz, Adam J. , Suhy, Joyce, Thompson, Paul M. , Weiner, Michael W. , Foster, Norman L. , Frisoni, Giovanni B. , Mangin, Jean‐François , Sperling, Reisa Anne , DeCarli, Charles , Bernstein, Matt A , Jack, Clifford R , Thompson, Paul M , Barkhof, Frederik , Scheltens, Philip , Fox, Nick C

Mayo Clinic

Alzheimer's & Dementia | July 25, 2011 | Volume: 7 | Issue: 4 | Pages: 474

10.1016/j.jalz.2011.04.007 | PMID 21784356 Get It

BackgroundThe promise of Alzheimer's disease biomarkers has led to their incorporation in new diagnostic criteria and in therapeutic trials; however, significant barriers exist to widespread use. Chief among these is the lack of internationally accepted standards for quantitative metrics. Hippocampal volumetry is the most widely studied quantitative magnetic resonance imaging measure in Alzheimer's disease and thus represents the most rational target for an initial effort at standardization.Methods and ResultsThe authors of this position paper propose a path toward this goal. The steps include the following: (1) Establish and empower an oversight board to manage and assess the effort, (2) adopt the standardized definition of anatomic hippocampal boundaries on magnetic resonance imaging arising from the European Alzheimer's Disease Centers–Alzheimer's Disease Neuroimaging Initiative hippocampal harmonization effort as a reference standard, (3) establish a scientifically appropriate, publicly available reference standard data set based on manual delineation of the hippocampus in an appropriate sample of subjects (Alzheimer's Disease Neuroimaging Initiative), and (4) define minimum technical and prognostic performance metrics for validation of new measurement techniques using the reference standard data set as a benchmark.ConclusionsAlthough manual delineation of the hippocampus is the best available reference standard, practical application of hippocampal volumetry will require automated methods. Our intent was to establish a mechanism for credentialing automated software applications to achieve internationally recognized accuracy and prognostic performance standards that lead to the systematic evaluation and then widespread acceptance and use of hippocampal volumetry. The standardization and assay validation process outlined for hippocampal volumetry was envisioned as a template that could be applied to other imaging biomarkers.
II. Stroke Rehabilitation
Peszczynski, M, Benson, D. Frank , Collins, Joyce M., Darley, Frederic L., Greenhouse, Arnold H., Katzen, Faye P., Lake, Lorraine F., Rothberg, June S., Waggoner, Raymond, Diller, Leonard

Mayo Clinic

Stroke | June 17, 2011 | Volume: 3 | Issue: 3 | Pages: 375-407

10.1161/01.str.3.3.375 Get It

Rehabilitation offers means by which persons disabled after a stroke can be returned to patterns of daily living as close to normal as possible. Often simple and readily available restorative techniques suffice, but sophisticated methods and facilities may be needed in many cases. Certain complex problems require specialized attention by persons with detailed knowledge and specific training. Among these are rehabilitation of language and the management of incontinence, sensory loss, pain, spasticity, and psychosocial problems. High-quality rehabilitation is best delivered by a closely cooperating team, including the family physician, medical specialists, nurses, allied health professionals (physical therapist, occupational therapist, social worker, dietitian, rehabilitation counselor, speech therapist, psychologist), the patient's family, and also the patient. To accomplish these ends, hospitals, rehabilitation centers, extended care facilities, and nursing homes should give specific attention to the special needs of stroke patients. Careful discharge planning and follow-up are necessary in all cases. The home environment and the family attitudes may require considerable revision to meet the patient's individual needs. The family physician can offer many rehabilitation services in his office, and additional education in medical school and on a postgraduate level will belp him to reach his full potential in aiding both the acutely ill and the chronically disabled stroke patient.
Effect of Guglielmi Detachable Coils on Experimental Carotid Artery Aneurysms in Primates
Tenjin, Hiroshi , Fushiki, Shinji , Nakahara, Yoshikazu, Masaki, Hiroto, Matsuo, Takamasa, Ueda, Satoshi, Johnson, Christopher M.

Mayo Clinic

Stroke | June 17, 2011 | Volume: 26 | Issue: 11 | Pages: 2075-2080

10.1161/01.str.26.11.2075 | PMID 7482653 Get It

Background and Purpose Clinical experience has established that intravascularly placed metal coils can be a useful treatment for cerebral vascular aneurysms. However, the mechanism by which the coils induce occlusion of the aneurysm is unclear. Appropriate use of this promising treatment modality requires basic understanding of the occlusive process. We used an animal model system of experimentally induced carotid aneurysms to investigate the initial events induced by Guglielmi detachable coils (GDCs), as well as the subsequent vascular changes induced by the coils over time. Methods We induced 23 aneurysms in the carotid arteries of 16 Japanese monkeys. Nineteen aneurysms were then occluded with GDCs placed via endovascular surgery; 4 aneurysms served as controls. We then used gross and microscopic pathological examination, angiography, and scanning electron microscopy to assess the effects of the GDC. Results In the first few hours after placement of the GDC in the experimental aneurysms, we observed leukocyte attachment and deposition of fibrinlike materials and other proteins. By 4 days after coil placement, leukocytes and fibroblasts were observed in the thrombus. By 2 weeks after coil placement, there was evidence of an endothelial-like covering of the coils. At 3 months after coil placement, we observed development of an arterial media in the occluded aneurysms. Conclusions The GDCs initiated a cellular response within several hours of aneurysm occlusion. By 2 weeks after coil placement, endothelialization was proceeding, and by 3 months after occlusion, remodeling of the aneurysm had progressed to produce a media-like structure in the former aneurysm.
Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
Li, Yafei , Sun, Zhifu , Cunningham, Julie M. , Aubry, Marie Christine, Wampfler, Jason A. , Croghan, Gary A., Johnson, Cassandra, Wu, Danli, Aakre, Jeremiah A. , Molina, Julian R. , Wang, Liewei , Pankratz, V. Shane , Yang, Ping , Sun, Zhifu

Mayo Clinic

Clinical Cancer Research | June 3, 2011 | Volume: 17 | Issue: 11 | Pages: 3830-3840

10.1158/1078-0432.ccr-10-2877 | PMID 21636554 Get It

Abstract Purpose: Variations in genes related to biological activity of anticancer drugs could influence treatment responses and lung cancer prognosis. Genetic variants in four biological pathways, that is, glutathione metabolism, DNA repair, cell cycle, and epidermal growth factor receptor (EGFR), were systematically investigated to examine their association with survival in advanced stage non–small cell lung cancer (NSCLC) treated with chemotherapy. Experimental Design: A total of 894 tagging single-nucleotide polymorphisms (SNP) in 70 genes from the four pathways were genotyped and analyzed in a 1,076-patient cohort. Association with overall survival was analyzed at SNP and whole-gene levels within all patients and major chemotherapy agent combination groups. Results: A poorer overall survival was observed in patients with genetic variations in GSS (glutathione pathway) and MAP3K1 (EGFR pathway; HR = 1.45; 95% CI = 1.20–1.77 and HR = 1.25; 95% CI = 1.05–1.50, respectively). In the stratified analysis on patients receiving platinum plus taxane treatment, we observed a hazardous effect on overall survival by the MAP3K1 variant (HR = 1.38; 95% CI = 1.11–1.72) and a protective effect by RAF1 (HR = 0.64; 95% CI = 0.50–0.82) in the EGFR pathway. In patients receiving platinum plus gemcitabine treatment, RAF1 and GPX5 (glutathione pathway) genetic variations showed protective effects on survival (HR = 0.54; 95% CI = 0.38–0.77; HR = 0.67; 95% CI = 0.52–0.85, respectively); in contrast, NRAS (EGFR pathway) and GPX7 (glutathione pathway) variations showed hazardous effects on overall survival (HR = 1.91; 95% CI = 1.30–2.80; HR = 1.83; 95% CI = 1.27–2.63, respectively). All genes that harbored these significant SNPs remained significant by whole-gene analysis. Conclusion: Common genetic variations in genes of EGFR and glutathione pathways may be associated with overall survival among patients with advanced stage NSCLC treated with platinum, taxane, and/or gemicitabine combinations. Clin Cancer Res; 17(11); 3830–40. ©2011 AACR.
Incidence and Symptoms of High Altitude Illness in South Pole Workers: Antarctic Study of Altitude Physiology (ASAP)
Anderson, Paul J., O’Malley, Kathy A., Ceridon, Maile L., Beck, Kenneth C., Wood, Christina M., Wiste, Heather J. , Mueller, J. , Johnson, Jacob, Johnson, Bruce D., Miller, Andrew David

Mayo Clinic

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | May 29, 2011 | Volume: 5 | Issue: No issue available | Pages: CCRPM.S6882

10.4137/ccrpm.s6882 | PMID 21695160 Get It

Introduction Each year, the US Antarctic Program rapidly transports scientists and support personnel from sea level (SL) to the South Pole (SP, 2835 m) providing a unique natural laboratory to quantify the incidence of acute mountain sickness (AMS), patterns of altitude related symptoms and the field effectiveness of acetazolamide in a highly controlled setting. We hypothesized that the combination of rapid ascent (3 hr), accentuated hypobarism (relative to altitude), cold, and immediate exertion would increase altitude illness risk. Methods Medically screened adults (N = 246, age = 37 ± 11 yr, 30% female, BMI = 26 ± 4 kg/m 2 ) were recruited. All underwent SL and SP physiological evaluation, completed Lake Louise symptom questionnaires (LLSQ, to define AMS), and answered additional symptom related questions (eg, exertional dyspnea, mental status, cough, edema and general health), during the 1st week at altitude. Acetazolamide, while not mandatory, was used by 40% of participants. Results At SP, the barometric pressure resulted in physiological altitudes that approached 3400 m, while T ° C averaged -42, humidity 0.03%. Arterial oxygen saturation averaged 89% ± 3%. Overall, 52% developed LLSQ defined AMS. The most common symptoms reported were exertional dyspnea-(87%), sleeping difficulty-(74%), headache-(66%), fatigue-(65%), and dizziness/lightheadedness-(46%). Symptom severity peaked on days 1-2, yet in >20% exertional dyspnea, fatigue and sleep problems persisted through day 7. AMS incidence was similar between those using acetazolamide and those abstaining (51 vs. 52%, P = 0.87). Those who used acetazolamide tended to be older, have less altitude experience, worse symptoms on previous exposures, and less SP experience. Conclusion The incidence of AMS at SP tended to be higher than previously reports in other geographic locations at similar altitudes. Thus, the SP constitutes a more intense altitude exposure than might be expected considering physical altitude alone. Many symptoms persist, possibly due to extremely cold, arid conditions and the benefits of acetazolamide appeared negligible, though it may have prevented more severe symptoms in higher risk subjects.
AJR Teaching File: Left Neck Mass Evaluated by PET/CT
Johnson, Geoffrey B. , Peller, Patrick J., Bahrami, Armita , Subramaniam, Rathan M. , Johnson, Geoffrey B. , Johnson, Geoffrey B , Johnson, Geoffrey B

Mayo Clinic

American Journal of Roentgenology | May 23, 2011 | Volume: 196 | Issue: 6_supplement | Pages: WS78-WS82

10.2214/ajr.10.7242 | PMID 21606245 Get It

National CT Colonography Trial (ACRIN 6664): Comparison of Three Full-Laxative Bowel Preparations in More Than 2500 Average-Risk Patients
Hara, Amy K., Kuo, Mark , Blevins, Meridith , Chen, Mei‐Hsiu , Dachman, Abraham H. , Menias, Christine O. , Siewert, Betina, Cheema, Jugesh I., Obregon, Richard G., Fidler, Jeff L. , Zimmerman, Peter, Horton, Karen M., Iyer, Revathy B., Halvorsen, Robert A., Casola, Giovanna, Johnson, C. Daniel, Yee, Judy , Fidler, Jeff L. , Coakley, Kevin J.

Mayo Clinic

American Journal of Roentgenology | April 21, 2011 | Volume: 196 | Issue: 5 | Pages: 1076-1082

10.2214/ajr.10.4334 | PMID 21512073 Get It

Use of Bioidentical Compounded Hormones for Menopausal Concerns: Cross-Sectional Survey in an Academic Menopause Center
Iftikhar, Salma , Shuster, Lynne T., Johnson, Ruth E. , Jenkins, Sarah M. , Wahner‐Roedler, Dietlind L.

Mayo Clinic

Journal of Women's Health | April 12, 2011 | Volume: 20 | Issue: 4 | Pages: 559-565

10.1089/jwh.2009.1915 | PMID 21486160 Get It

Is obesity deflating?
Johnson, Bruce D., Babb, Tony G.

Mayo Clinic

Journal of Applied Physiology | April 8, 2011 | Volume: 111 | Issue: 1 | Pages: 2-4

10.1152/japplphysiol.00386.2011 | PMID 21474697 Get It

Antigen Retrieval of Basement Membrane Proteins from Archival Eye Tissues
Hann, Cheryl R., Springett, Margaret J., Johnson, Douglas H.

Mayo Clinic

Journal of Histochemistry & Cytochemistry | April 1, 2011 | Volume: 49 | Issue: 4 | Pages: 475-482

10.1177/002215540104900407 | PMID 11259450 Get It

Antigen retrieval (AR) methods can unmask tissue antigens that have been altered by fixation, processing, storage, or resin interactions. This is particularly important in the study of archival tissues, because primary fixatives and storage times may vary among specimens. We performed an electron microscopic study of basement membrane components of the aqueous humor drainage pathways from archival eye tissue. AR (heated citrate buffer, pH 6.0, LR White resin) increased the amount of label of collagen IV and fibronectin in tissue fixed in four different fixatives, including those containing glutaraldehyde. Labeling density was approximately doubled after AR for most fixatives, with the largest increase for tissues fixed in 4% paraformaldehyde/2% glutaraldehyde. Duration of storage time for archival tissues did not affect AR results. AR did not change the components of the extracellular matrix labeled; no “new” components were labeled after AR. We conclude that AR in citrate buffer can be used on selected extracellular matrix antigens to enhance label that would otherwise be lost due to fixation and storage.